Cardiovascular Safety of VEGF-Targeting Therapies: Current Evidence and Handling Strategies

Por Girardi, Fabio, Franceschi, Enrico, Brandes, Alba A.
Publicado em 2010

Practical Management of Bevacizumab-Related Toxicities in Glioblastoma

Por Brandes, Alba A., Bartolotti, Marco, Tosoni, Alicia, Poggi, Rosalba, Franceschi, Enrico
Publicado no Oncologist (2015)

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology

Por Brandes, Alba A., Tosoni, Alicia, Spagnolli, Federica, Frezza, Giampiero, Leonardi, Marco, Calbucci, Fabio, Franceschi, Enrico
Publicado em 2008

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (<it>SNURF<...

Por Pession Annalisa, Ermani Mario, Tosoni Alicia, Marucci Gianluca, de Biase Dario, Franceschi Enrico, Morandi Luca, Tallini Giovanni, Brandes Alba
Publicado em 2010-02-01

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as...

Por Morandi, Luca, Franceschi, Enrico, de Biase, Dario, Marucci, Gianluca, Tosoni, Alicia, Ermani, Mario, Pession, Annalisa, Tallini, Giovanni, Brandes, Alba
Publicado em 2010

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma

Por Schiffgens, Salveena, Wilkens, Ludwig, Brandes, Alba A., Meier, Tatiana, Franceschi, Enrico, Ermani, Mario, Hartmann, Christian, Sandalcioglu, Ibrahim Erol, Dumitru, Claudia A.
Publicado no Oncotarget (2016)

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

Por Franceschi, Enrico, Stupp, Roger, van den Bent, Martin J., van Herpen, Carla, Laigle Donadey, Florence, Gorlia, Thierry, Hegi, Monika, Lhermitte, Benoit, Strauss, Lewis C., Allgeier, Anouk, Lacombe, Denis, Brandes, Alba A.
Publicado em 2012

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Por Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Caserta, Claudia, Fabi, Alessandra, Clavarezza, Matteo, Maiello, Evaristo, Eoli, Marica, Lombardi, Giuseppe, Monteforte, Marta, Proietti, Emanuela, Agati, Raffaele, Eusebi, Vincenzo, Franceschi, Enrico
Publicado no Neuro Oncol (2016)

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implicatio...

Por Brandes, Alba A., Franceschi, Enrico, Tosoni, Alicia, Bartolini, Stefania, Bacci, Antonella, Agati, Raffaele, Ghimenton, Claudio, Turazzi, Sergio, Talacchi, Andrea, Skrap, Miran, Marucci, Gianluca, Volpin, Lorenzo, Morandi, Luca, Pizzolitto, Stefano, Gardiman, Marina, Andreoli, Alvaro, Calbucci, Fabio, Ermani, Mario
Publicado em 2010

AT-11 FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM

Por Brandes, Alba A., Finocchiaro, Gaetano, Zagonel, Vittorina, Reni, Michele, Fabi, Alessandra, Caserta, Claudia, Clavarezza, Matteo, Maiello, Evaristo, Cartenì, Giacomo, Rosti, Giovanni, Eoli, Marica, Lombardi, Giuseppe, Monteforte, Marta, Agati, Raffaele, Eusebi, Vincenzo, Galli, Anna, Doria, Simona, Franceschi, Enrico
Publicado em 2014

NI-26 COMPARATIVE ANALYSIS OF THE RANO AND MACDONAD'S CRITERIA IN RECURRENT GLIOBLASTOMA TREATED IN THE RANDOMIZED PHASE II TRIAL AVAREG WITH BEVACIZUMAB OR FOTEMUSTINE.

Por Franceschi, Enrico, Agati, Raffaele, Finocchiaro, Gaetano, Zagonel, Vittorina, Fabi, Alessandra, Reni, Michele, Caserta, Claudia, Maiello, Evaristo, Cartenì, Giacomo, Clavarezza, Matteo, Rosti, Giovanni, Eoli, Marica, Lombardi, Giuseppe, Bacci, Antonella, Monteforte, Marta, Doria, Simona, Galli, Anna, Brandes, Alba A.
Publicado em 2014

NIMG-56 IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP

Por Okada, Hideho, Weller, Michael, Huang, Raymond, Finocchiaro, Gaetano, Gilbert, Mark, Wick, Wolfgang, Ellingson, Benjamin, Hashimoto, Naoya, Pollack, Ian, Brandes, Alba, Franceschi, Enrico, Herold-Mende, Christel, Nayak, Lakshmi, Panigrahy, Ashok, Pope, Whitney, Prins, Robert, Sampson, John, Wen, Patrick, Reardon, David
Publicado no Neuro Oncol (2015)

Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications

Por Brandes, Alba A., Franceschi, Enrico, Paccapelo, Alexandro, Tallini, Giovanni, De Biase, Dario, Ghimenton, Claudio, Danieli, Daniela, Zunarelli, Elena, Lanza, Giovanni, Silini, Enrico Maria, Sturiale, Carmelo, Volpin, Lorenzo, Servadei, Franco, Talacchi, Andrea, Fioravanti, Antonio, Pia Foschini, Maria, Bartolini, Stefania, Pession, Annalisa, Ermani, Mario
Publicado no Oncologist (2017)

Immunotherapy Response Assessment in Neuro-Oncology (iRANO): A Report of the RANO Working Group

Por Okada, Hideho, Weller, Michael, Huang, Raymond, Finocchiaro, Gaetano, Gilbert, Mark R., Wick, Wolfgang, Ellingson, Benjamin M., Hashimoto, Naoya, Pollack, Ian F., Brandes, Alba A., Franceschi, Enrico, Herold-Mende, Christel, Nayak, Lakshmi, Panigrahy, Ashok, Pope, Whitney B., Prins, Robert, Sampson, John H., Wen, Patrick Y., Reardon, David A.
Publicado no Lancet Oncol (2015)

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-vo...

Por Brandes, Alba A., Franceschi, Enrico, Ermani, Mario, Tosoni, Alicia, Albani, Fiorenzo, Depenni, Roberta, Faedi, Marina, Pisanello, Anna, Crisi, Girolamo, Urbini, Benedetta, Dazzi, Claudio, Cavanna, Luigi, Mucciarini, Claudia, Pasini, Giuseppe, Bartolini, Stefania, Marucci, Gianluca, Morandi, Luca, Zunarelli, Elena, Cerasoli, Serenella, Gardini, Giorgio, Lanza, Giovanni, Silini, Enrico Maria, Cavuto, Silvio, Baruzzi, Agostino
Publicado no Neurooncol Pract (2014)